| Sector |
Fast Moving Consumer Goods
|
Compare with Sector peers |
| Industry |
Animal Feed
|
Compare with Industry peers |
| Website | http://www.ajoonibiotech.com | |
| Market Cap | 56.51 Cr. | |
| Enterprise Value(EV) | 60.04 Cr. | 2023-12 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.20 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 31.62 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 33.19 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 4.90 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.32 | Calculated using Price: 6.45 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 8.76 Cr. | 87,613,721 Shares |
| FaceValue | 2 | |
| About Ajooni Biotech Ltd. | ||
| The company is a paramount manufacturer and supplier of superior quality of Patanjali Samvriddhi, Patanjali Garbhanjali, Patanjali Batisa-Pro etc. The products offered by them are processed using quality ingredients sourced from the trustworthy vendors of the market. Their range is appreciated for their features such as hygiene, accurate composition and easy to use. The offered range is processed under Quality certified manufacturing unit. Their manufactured veterinary products find use in the treatment and cure of many diseases in animals. Besides, they also undertake contracts for analytical method developments and stability studies. Available in air tight & hygienic packs, these medicines are highly appreciated for their accurate composition, precise pH value, effectiveness and longer shelf life. | ||
| 1 Day |
|
+1.57% |
| 1 Week |
|
+7.50% |
| 1 Month |
|
+17.27% |
| 3 Month |
|
-0.77% |
| 6 Month |
|
+50.0% |
| 1 Year |
|
+30.30% |
| 2 Year |
|
-43.52% |
| 5 Year |
|
+124.74% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 18.72 | 20.38 | 36.98 | 6.8 | 3.72 | 2.54 | 2.4 | 6.58 | 3.87 | |
| Return on Capital Employed (%) | 27.57 | 18.62 | 36.19 | 10.03 | 3.84 | 4.35 | 5.07 | 9.09 | 5.99 | |
| Return on Assets (%) | 6.89 | 4.78 | 3.61 | 2.4 | 2.2 | 1.69 | 1.47 | 3.7 | 2.58 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12* Rs. Cr. |
| Shh. Funds | 0 | 1 | 1 | 11 | 12 | 16 | 16 | 16 | 42 | 41 | |
| Non Curr. Liab. | 0 | 4 | 2 | 4 | 1 | 2 | 2 | 2 | 2 | ||
| Curr. Liab. | 1 | 2 | 8 | 6 | 2 | 6 | 10 | 10 | 15 | 15 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 58 | 58 | |
| Non Curr. Assets | 0 | 0 | 7 | 8 | 6 | 5 | 6 | 7 | 24 | 16 | |
| Curr. Assets | 1 | 2 | 6 | 11 | 12 | 18 | 21 | 22 | 35 | 42 | |
| Misc. Exp. not W/O | 1 | 0 | 0 | 0 | |||||||
| Total Assets | 2 | 2 | 13 | 19 | 18 | 23 | 28 | 29 | 58 | 58 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 7 | 13 | 29 | 42 | 40 | 40 | 51 | 74 | 74 | 102 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Total Income | 7 | 13 | 29 | 43 | 40 | 40 | 51 | 74 | 75 | 104 | |
| Total Expenditure | -7 | -13 | -28 | -41 | -39 | -39 | -49 | -71 | -72 | -100 | |
| PBIDT | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | |
| Interest | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | -1 | ||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | |
| Adjusted EPS | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | -1 | -5 | -4 | 1 | 4 | -6 | |||
| Cash Fr. Inv. | 0 | 0 | 0 | 1 | 0 | -3 | -2 | -16 | |||
| Cash Fr. Finan. | 0 | 0 | 1 | -1 | 3 | 2 | -2 | 22 | |||
| Net Change | 0 | 0 | 0 | -5 | -1 | 0 | 0 | 0 | |||
| Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations Ajooni Biotech Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ |
|
Tue, 23 Apr 2024
Disclosure under SEBI Takeover Regulations Jasjot Singh has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Mon, 22 Apr 2024
Updates Ajooni Biotech Limited has informed the Exchange regarding 'CONNECTING WITH AVON ANIMAL HEALTH, (ONE OF THE LEADING COMPANY OF BANGLADESH)'. |
| Wed, 24 Apr 2024 |
Making Higher Highs for 3 days
|
Making Higher Highs for 2 Days
|
High Increase in 1 Month
|
High Increase in 6 Months
|
High Increase in 5 Years
|
